127 Pembrolizumab Monotherapy for Locally Advanced or Metastatic Non–Small-Cell Lung Cancer (NSCLC): 10-Year Outcomes From Clinical Trials
Fields of Study & Subjects
Lung Cancer Treatments and Mutations
Cancer Immunotherapy and Biomarkers
Lung Cancer Diagnosis and Treatment
Publication details
- Journal / source
- Lung Cancer
- Volume
- 212
- Pages
- 109076–109076
- Publication date
- 1 February 2026
- Language
- EN